Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy. | Res Sq | 2023 | 37333340 | PubTator, text mining | PubMed |
| Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression. | Oncol Lett | 2023 | 37332329 | PubTator, text mining | PubMed |
| A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes. | Sci Rep | 2023 | 37328616 | PubTator, text mining | PubMed |
| Bovine Rectoanal Junction In Vitro Organ Culture Model System to Study Shiga Toxin-Producing Escherichia coli Adherence. | Microorganisms | 2023 | 37317263 | PubTator, text mining | PubMed |
| The intermediate filament protein nestin serves as a molecular hub for smooth muscle cytoskeletal signaling. | Respir Res | 2023 | 37316833 | PubTator, text mining | PubMed |
| Targeting CDK1 in cancer: mechanisms and implications. | NPJ Precis Oncol | 2023 | 37311884 | PubTator, text mining | PubMed |
| Alterations in cytoskeletal and Ca2+ cycling regulators in atria lacking the obscurin Ig58/59 module. | Front Cardiovasc Med | 2023 | 37304957 | PubTator, text mining | PubMed |
| Metastatic Dissemination: Role of Tumor-Derived Extracellular Vesicles and Their Use as Clinical Biomarkers. | Int J Mol Sci | 2023 | 37298540 | PubTator, text mining | PubMed |
| Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances. | Int J Mol Sci | 2023 | 37298365 | PubTator, text mining | PubMed |
| SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease. | Atheroscler Plus | 2023 | 37293388 | PubTator, text mining | PubMed |
| Membrane trafficking in breast cancer progression: protein kinase D comes into play. | Front Cell Dev Biol | 2023 | 37293129 | PubTator, text mining | PubMed |
| PZR promotes tumorigenicity of lung cancer cells by regulating cell migration and invasion via modulating oxidative stress and cell adhesion. | Aging (Albany NY) | 2023 | 37279992 | PubTator, text mining | PubMed |
| Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility. | J Biol Chem | 2023 | 37271338 | PubTator, text mining | PubMed |
| Dynamic modulation of matrix adhesiveness induces epithelial-to-mesenchymal transition in prostate cancer cells in 3D. | Biomaterials | 2023 | 37267701 | PubTator, text mining | PubMed |
| Disruption of axonal transport in neurodegeneration. | J Clin Invest | 2023 | 37259916 | PubTator, text mining | PubMed |
| EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? | Mol Cancer | 2023 | 37259089 | PubTator, text mining | PubMed |
| Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model. | J Neurosci | 2023 | 37253603 | PubTator, text mining | PubMed |
| ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion. | Breast Cancer (Dove Med Press) | 2023 | 37252376 | PubTator, text mining | PubMed |
| Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design. | Bioorg Chem | 2023 | 37244230 | PubTator, text mining | PubMed |
| Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. | Biomedicines | 2023 | 37238995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=16